Drug manufacturers recommend women stop taking weight loss drugs at least two months before a planned pregnancy, as not enough research has been done to fully assess the risks of taking GLP-1 medications while pregnant, according to Dr
Parker WD Jr., Parks JK, Filley CM, Kleinschmidt-DeMasters BK
Most clinical data on insulin signaling in thyroid cancer derive from the hypothesis that insulin-resistance, typical of obesity, metabolic syndrome and T2DM, could be a risk factor for thyroid cancer development (Malaguarnera et al., 2017)
Effects of Qijian mixture on type 2 diabetes assessed by metabonomics, gut microbiota and network pharmacology
Where should GLOW be injected